Delivery Order SPE2DB22D2206-SPE2DB25FGS08
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mercaptopurine 50 mg tablets (250-count units) with a ceiling value of $11,142.08. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mercaptopurine is an antimetabolite medication commonly used in cancer...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Mercaptopurine 50 mg tablets in a quantity of 250 units, with a contract ceiling value of $2,011.88. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by November 5, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is a child...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mercaptopurine 50 mg tablets. The firm-fixed-price contract has a ceiling value of $3,448.53 and a completion date of September 30, 2024. It is not associated with a set-aside program. Amerisourcebergen, through its extensive supply chain network, will provide this critical medication to support military treatment facilities and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 13, 2025, for the supply of Mercaptopurine 50 mg tablets in a quantity of 250s, with a ceiling value of $2,211.36. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is set to be completed by February 14, 2025, and will be performed at AmerisourceBergen's corporate headquarters in...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,927.08, is for the supply of Mercaptopurine 20 mg/mL suspension, a medication used to treat certain types of cancer. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,417.53 to AmerisourceBergen Drug Corp for the supply of Mercaptopurine 50 mg tablets (250 count) under a firm fixed-price contract. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mercaptopurine 50 MG tablets in 250-count quantities, with a ceiling value of $1,474.24. The delivery order has a firm-fixed price pricing type and is set to be completed by June 10, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
- This delivery order for $3,305.46, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, is for the purchase of 250 tablets of 50 mg mercaptopurine. The order has a firm fixed price and place of performance in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. The completion date is October 24, 2023, with an award date of October 23, 2023. As the Defense Logistics Agency manages the global supply chain for the Department of Defense, this order...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The $1,552.39 firm fixed-price contract is for the supply of Mercaptopurine 50 mg tablets. The contract has an ultimate completion date of December 15, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within the military and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,304.84 firm fixed price contract is for the supply of 4563144789 - MERCAPTOPURINE 50 MG TABLET 25S pharmaceutical products. The contract has a completion date of December 20, 2023 and was awarded on December 19, 2023. No set-aside designations were used. AmerisourceBergen Drug Corp is a prime contractor that provides pharmaceutical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FGS08Delivery Order
The Defense Logistics Agency awarded a $5,767.74 delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Mercaptopurine 20 mg/ml suspension in 100 ml quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of April 24, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. Mercaptopurine is a critical immunosuppressant and chemotherapy medication used in military and veteran healthcare settings. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. As one of the government's major pharmaceutical distributors, AmerisourceBergen has demonstrated consistent capability to meet federal procurement requirements through competitive award processes, with this delivery order representing a routine fulfillment under the larger strategic pharmaceutical prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 4/23/25 |